Epidemiologic Methods for Measuring Vaccine Hesitancy
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".
Deadline for manuscript submissions: closed (28 February 2025) | Viewed by 232
Special Issue Editor
Interests: epidemiology; health equity; vaccination coverage
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
I am pleased to invite you to contribute an original research article or review to our Special Issue of Vaccines, titled “Epidemiologic Methods for Measuring Vaccine Hesitancy”.
Vaccine hesitancy, defined as “the delay in acceptance or refusal of vaccination despite the availability of vaccination services”, is considered one of the top 10 threats to global health according to the World Health Organization. Measuring hesitancy toward COVID-19 or other routine recommended vaccinations is important in developing targeted messages or strategies to increase vaccination uptake or confidence. Up-to-date and novel approaches for measuring vaccine hesitancy and confidence are needed. This Special Issue will examine epidemiologic methods for measuring the uptake of, and hesitancy toward, routine and COVID-19 vaccines, the strengths and limitations of each epidemiologic method, and possible methods for improving the measurement of vaccine uptake and hesitancy. Research areas may include (but are not limited to) the following: vaccine hesitancy, vaccine confidence, COVID-19, routinely recommended vaccines, vaccination epidemiology, vaccination frameworks, vaccination strategies, and vaccination surveillance.
I look forward to receiving your contributions.
Dr. Laura Corlin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine hesitancy
- vaccine confidence
- COVID-19
- routinely recommended vaccines
- epidemiologic methods
- conceptual frameworks
- strategies
- surveillance
- children
- adolescents
- adults
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
